| Travere Therapeutics, Inc. | TVTX | Peter HeermaChiefDERIV | Sep 17 | MPLAN | 8,282 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChiefDERIV | Sep 16 | MPLAN | 17,717 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChiefDERIV | Sep 16 | MPLAN | 55,000 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChiefDERIV | Sep 16 | MPLAN | 100,000 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChiefDERIV | Sep 15 | MPLAN | 36,526 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChiefDERIV | Sep 15 | MPLAN | 1,381 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChiefDERIV | Sep 15 | MPLAN | 39,283 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Sep 17 | SPLAN | 8,282 | $65.07 | $539K |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Sep 17 | MPLAN | 8,282 | $22.40 | $186K |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Sep 16 | SPLAN | 79,113 | $63.65 | $5.0M |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Sep 16 | SPLAN | 93,604 | $63.25 | $5.9M |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Sep 16 | MPLAN | 17,717 | $26.88 | $476K |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Sep 16 | MPLAN | 55,000 | $15.46 | $850K |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Sep 16 | MPLAN | 100,000 | $11.25 | $1.1M |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Sep 15 | SPLAN | 1,431 | $65.31 | $93K |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Sep 15 | SPLAN | 1,400 | $63.65 | $89K |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Sep 15 | SPLAN | 27,421 | $62.59 | $1.7M |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Sep 15 | SPLAN | 71,938 | $62.05 | $4.5M |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Sep 15 | MPLAN | 36,526 | $8.93 | $326K |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Sep 15 | MPLAN | 1,381 | $22.40 | $31K |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Sep 15 | MPLAN | 39,283 | $26.88 | $1.1M |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChiefDERIV | May 4 | M | 4,250 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChiefDERIV | May 4 | A | 8,500 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | May 5 | S | 2,174 | $46.65 | $101K |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | May 4 | M | 4,250 | $0.00 | — |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Apr 14 | S | 7,215 | $41.93 | $303K |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Apr 13 | A | 14,000 | $0.00 | — |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChiefDERIV | Jan 31 | A | 69,640 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Feb 3 | S | 7,310 | $32.12 | $235K |
| Travere Therapeutics, Inc. | TVTX | Peter HeermaChief | Jan 31 | A | 26,120 | $0.00 | — |